Emcure Pharmaceuticals Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Emcure Pharmaceuticals Limited
Symbol
EMCURE
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Not Applicable
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
23-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.emcure.com/investors/#reports#annual-returns
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://www.emcure.com/investors/#financials
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.emcure.com/investors/#reports#newspaper-advertisements
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.emcure.com/wp-content/uploads/2025/05/Dividend-Distribution-Policy_adopted-15.12.2023.pdf
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.emcure.com/wp-content/uploads/2025/05/Policy-for-Determining-Materiality-of-Events-and-Information-for-Disclosures_adopted-15.12.2023.pdf
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.emcure.com/investors/
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://www.emcure.com/investors/#reports#credit-ratings
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.emcure.com/about-us/
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.emcure.com/wp-content/uploads/2026/02/EPL_Vigil-Mechanism-Policy_04.02.2026.pdf
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.emcure.com/investors/#financials
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.emcure.com/wp-content/uploads/2025/05/Policy-for-Determining-Material-Subsidiaries_Amendment_06.02.2025F.pdf
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.emcure.com/wp-content/uploads/2025/05/Related-Party-Transactions-Policy_Amendment-06.02.2025F.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.emcure.com/investors/#governance#other-information#shareholding-patterns
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.emcure.com/investors/
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.emcure.com/investors/
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.emcure.com/wp-content/uploads/2026/02/Reg305.pdf
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.emcure.com/investors/
Disclosure Web Link Of Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021Is Placed
https://www.emcure.com/wp-content/uploads/2025/05/Emcure-Employee-Stock-Option-Scheme-2013.pdf
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.emcure.com/wp-content/uploads/2025/05/EPL-COI-MOA-AOA.pdf
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://www.emcure.com/investors/#governance#other-information#schedule-of-analysts-or-institutional-investors-meet
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.emcure.com/investors/
Disclosure Web Link Of Statements Of Deviations Or Variations As Specified In Regulation32Is Placed
https://www.emcure.com/investors/#governance#other-information#disclosures-under-regulation-32
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Yes
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE168P01015
Market Capitalisation As Per Immediate Previous Financial Year
Top 500 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Amruta Yangalwar
Name Of Signatory Affirmations
Amruta Yangalwar
Name Of Signatory For Annual Affirmations
Amruta Yangalwar
Name Of Signatory For Quartely Affirmations
Amruta Yangalwar
Name Of The Company
EMCURE PHARMACEUTICALS LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Pune
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
No loan (or other form of debt), guarantee / comfort letter (by whatever name called) or security provided in connection with any loan or any other form of debt has been given directly or indirectly by the Company to any company other than those exluded in reference to notes of the said disclosures, for the period January 01, 2026 to March 31, 2026.
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
COME00369
Scrip Code
544210
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Yes
Symbol
EMCURE
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Not Applicable
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

Disclosure Of Notes On Composition Of Board Of Directors Explanatory Text Block
The Company has made following appointments/ re-appointments, basis recommendation of Nomination and Remuneration Committee: 1. Mr. Vijay Keshav Gokhale (DIN: 09134089) has been re-appointed as an Independent Director of the Company for second term of 5 (five) consecutive years commencing from April 16, 2026. 2. Dr. Vidya Rajiv Yeravdekar (DIN: 02183179) has been re-appointed as an Independent Director of the Company for second term of 3 (three) consecutive years commencing from April 16, 2026. 3. Dr. Shailesh Kripalu Ayyangar (DIN: 00268076) has been re-appointed as an independent director of the Company for second term of 5 (five) consecutive years commencing from June 02, 2026. 4. Mr. C S Muralidharan (DIN: 00014740) has been appointed as an Additional Director (Non-Executive and Independent Director) of the Company by the Board of Directors in their meeting held on March 09, 2026 subject to approval of Members.
The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionSpecial Resolution DateInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrBerjis Minoo Desai******00153675Non-Executive - Non Independent DirectorChairperson02-Aug-1956NoActiveNot Applicable03-Apr-199728-Jul-20226151
2MrSatish Ramanlal Mehta******00118691Executive DirectorNot ApplicableCEO-MD13-Jan-1951NoActiveNot Applicable16-Apr-198101-Apr-20221010
3MrSunil Rajanikant Mehta******00118469Executive DirectorNot Applicable23-Mar-1963NoActiveNot Applicable05-Jun-201305-Jun-20231000
4MrsNamita Vikas Thapar******05318899Executive DirectorNot Applicable21-Mar-1977NoActiveNot Applicable28-Jul-201428-Jul-20242110
5MrSamit Satish Mehta******00332562Executive DirectorNot Applicable04-Apr-1980NoActiveNot Applicable28-Jul-202228-Jul-20221000
6MrMukund Keshao Gurjar******00026843Executive DirectorNot Applicable28-Aug-1952NoActiveNot Applicable23-Jul-200128-Aug-20251000
7MrPalamadai Sundararajan Jayakumar******01173236Non-Executive - Independent DirectorNot Applicable08-Apr-1962NoActiveNot Applicable22-Jul-202022-Jul-202368.17773
8MrVijay Keshav Gokhale******09134089Non-Executive - Independent DirectorNot Applicable24-Jan-1959NoActiveNot Applicable16-Apr-202116-Apr-202159.162230
9MrsVidya Rajiv Yeravdekar******02183179Non-Executive - Independent DirectorNot Applicable28-Jun-1964NoActiveNot Applicable16-Apr-202116-Apr-202159.162220
10MrShailesh Kripalu Ayyangar******00268076Non-Executive - Independent DirectorNot Applicable15-Oct-1954NoActiveYes20-Mar-202602-Jun-202302-Jun-202333.32241

Committee Disclosures

Entry CompComit122
Date of Appointment
26-Nov-2013
Entry CompComit123
Date of Appointment
21-Jun-2025
Entry CompComit124
Date of Appointment
27-Jul-2022
Entry CompComit14
Date of Appointment
22-Jul-2020
Entry CompComit15
Date of Appointment
17-Jun-2005
Entry CompComit16
Date of Appointment
27-Jul-2022
Entry CompComit41
Date of Appointment
27-Jul-2022
Entry CompComit42
Date of Appointment
16-Apr-2021
Entry CompComit43
Date of Appointment
31-Dec-2024
Entry CompComit68
Date of Appointment
07-May-2011
Entry CompComit69
Date of Appointment
07-May-2011
Entry CompComit70
Date of Appointment
27-Jul-2022
Entry CompComit95
Date of Appointment
02-Jun-2023
Entry CompComit96
Date of Appointment
27-Jul-2021
Entry CompComit97
Date of Appointment
27-Jul-2022
Entry CompComit98
Date of Appointment
21-Jun-2025
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.emcure.com/wp-content/uploads/2025/06/Composition-of-Committees_21.06.2025.pdf
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
01173236
Member Name
Palamadai Sundararajan Jayakumar
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00153675
Member Name
Berjis Minno Desai
Position
Non-Executive - Non Independent Director

Audit Committee

Additional Position
Member
Director DIN
09134089
Member Name
Vijay Keshav Gokhale
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
00118469
Member Name
Sunil Rajanikant Mehta
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00332562
Member Name
Samit Satish Mehta
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
09134089
Member Name
Vijay Keshav Gokhale
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
09134089
Member Name
Vijay Keshav Gokhale
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
01173236
Member Name
Palamadai Sundararajan Jayakumar
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00153675
Member Name
Berjis Minoo Desai
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Nomination and remuneration committee

Nomination and remuneration committee

Risk Management Committee

Additional Position
Chairperson
Director DIN
00268076
Member Name
Shailesh Kripalu Ayyangar
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
01173236
Member Name
Palamadai Sundararajan Jayakumar
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
09134089
Member Name
Vijay Keshav Gokhale
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
00118469
Member Name
Sunil Rajanikant Mehta
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
00153675
Member Name
Berjis Minno Desai
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00118691
Member Name
Satish Ramanlal Mehta
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
09134089
Member Name
Vijay Keshav Gokhale
Position
Non-Executive - Independent Director
Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
11-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
9
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
10
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
04-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
84
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
2
Total Number Of Directors As On Date Of The Meeting
10
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
09-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
32
Number Of Directors Present In Meeting Of Board Of Directors
9
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
10
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
11-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
04-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
84
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Previous Quarter
11-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
04-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
84
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
09-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
32
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Relevant Quarter
04-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.emcure.com/contact-us/#registered-office
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://www.emcure.com/contact-us/#registered-office
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
0
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Not Applicable
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
No event has occurred during the period January 01, 2026 to March 31, 2026, related to acquisition of shares or voting rights in unlisted companies, in terms of sub-para 1 of para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
The revised notice of demand is yet to be received from the Assessing officer in respect of Financial Year 2014-15 until Financial Year 2020-21. In case of Financial Year 2021-22, there is no further development.
Date of Initiation
27-Dec-2023
Opposing Party
Deputy Commissioner of Income tax, Central Circle 2 (1)- Pune
Status (Previous Disclosure)
The Company has received assessment orders u/s 143(3) rws 144C(3) and r.w.s 153A of the Income Tax Act, 1961, for the Financial Year 2014-15 until Financial Year 2020-21 (Assessment Year 2015-16 to Assessment Year 2021-22) for an aggregate demand of Rs. 1,828.15 million and order u/s 143(3) for Financial Year 2021-22 (Assessment Year 2022-23) for demand of Rs. 26.74 million payable on account of disallowance of certain advertisement and promotional expenses and transfer pricing adjustments made. The Company has filed appeals in relation to such orders with the Commissioner of Income Tax (Appeals). The Company has received orders dated 31-03-2026, passed by the CIT(A), in respect of appeals filed against the orders u/s. 153A of the Act for the Financial Year 2014-15 until Financial Year 2020-21 (Assessment Year 2015-16 to Assessment Year 2021-22), wherein certain relief on additions has been granted.
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
The cases are pending for disposal with Commissioner of Income Tax (Appeals).
Date of Initiation
22-Oct-2022
Opposing Party
Deputy Commissioner of Income tax, Central Circle 2 (1)- Pune
Status (Previous Disclosure)
Subsidiary of Company, Zuventus Healthcare Limited (Zuventus) has received assessment orders u/s 143(3) r.w.s 153A of the Income Tax Act, 1961, for the Financial Year 2014-15 until Financial Year 2020-21 (Assessment Year 2015-16 to Assessment Year 2021-22) for an aggregate demand of Rs. 1,077.83 million and order u/s 143(3) for Financial Year 2021-22 to Financial Year 2022-23 (Assessment Year 2022-23 to 2023-24) for demand of Rs. 33.40 million payable on account of disallowances of certain advertisement and promotional expenses. Zuventus has filed appeals in relation to such orders with the Commissioner of Income Tax (Appeals). The cases are pending for disposal with Commissioner of Income Tax (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes3
Current Status
The Company will file an appeal challenging the revised demand.
Date of Initiation
18-Sep-2025
Opposing Party
Deputy Commissioner of State Tax, LTUE604, Pune
Status (Previous Disclosure)
Show cause notice (SCN) under Section 73(1) of the CGST/ MGST Act, 2017 issued in connection with alleged misclassification in outward supply due to HSN and reconciliation of turnover based on TDS Return filed by customers. The general rate of GST on Pharmaceuticals products is @12% and some goods specified in GST Rate Notification 01/2017 are charged to GST @ 5%. The Authority has challenged 5% GST rate and issued SCN for differential rate of 7%. GST impact of issues raised in SCN is Rs. 712.83 million (including interest of Rs. 283.15 million and penalty of Rs. 66.52 million). The Company had submitted reply for the said SCN on 17-10-2025 and personal hearing was granted. Based on the personal hearing, an order has been passed on 17-12-2025. As per the Order, alleged HSN misclassification has been dropped. However, demand confirmed for difference in turnover with TDS Return filed by Customers. The revised demand is Rs. 402.14 million (including interest of Rs. 163.87 million and penalty of Rs. 21.66 million). The Company had filed application for rectification. Rectification order was received on 03-02-2026. As per said rectification order, the revised demand is Rs. 12.98 million (including interest of Rs. 5.65 million and penalty of Rs. 0.67 million)
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
No event has occurred, during the period January 01, 2026 to March 31, 2026, in terms of sub-para 20 of para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as per prescribed threshold
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No